REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML
Product details
Registration number: SIN16568P
Classification: Prescription Only
Active ingredients: Rilpivirine
Strength: 300mg/mL
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
ATC code: J05AG05
HSA approval date: 11 August 2022
Manufacturer(s): Cilag AG
Manufacturing country/countries: SWITZERLAND
What are the HSA registration number and classification for REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16568P
Classification: Prescription Only
What active ingredients and strength are recorded for REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Rilpivirine
Strength: 300mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: INTRAMUSCULAR
Who is the recorded registrant for REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: JOHNSON & JOHNSON INTERNATIONAL (SINGAPORE) PTE LTD
Which manufacturers and countries are listed for REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Cilag AG
Manufacturing country/countries: SWITZERLAND
Where can I look up REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16568P or the exact product name REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML. The general register link does not preselect this product.
What are the source dates for this REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REKAMBYS PROLONGED-RELEASE SUSPENSION FOR INJECTION 300MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16568P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)